Styryl-based and tricyclic compounds as potential anti-prion agents
about
Fluphenazine reduces proteotoxicity in C. elegans and mammalian models of alpha-1-antitrypsin deficiencyPharmacological chaperone reshapes the energy landscape for folding and aggregation of the prion proteinQuinacrine promotes replication and conformational mutation of chronic wasting disease prions.A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer's and Prion DiseasesResveratrol and Pterostilbene Exhibit Anticancer Properties Involving the Downregulation of HPV Oncoprotein E6 in Cervical Cancer Cells.
P2860
Styryl-based and tricyclic compounds as potential anti-prion agents
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Styryl-based and tricyclic compounds as potential anti-prion agents
@ast
Styryl-based and tricyclic compounds as potential anti-prion agents
@en
Styryl-based and tricyclic compounds as potential anti-prion agents
@nl
type
label
Styryl-based and tricyclic compounds as potential anti-prion agents
@ast
Styryl-based and tricyclic compounds as potential anti-prion agents
@en
Styryl-based and tricyclic compounds as potential anti-prion agents
@nl
prefLabel
Styryl-based and tricyclic compounds as potential anti-prion agents
@ast
Styryl-based and tricyclic compounds as potential anti-prion agents
@en
Styryl-based and tricyclic compounds as potential anti-prion agents
@nl
P2093
P2860
P50
P3181
P1433
P1476
Styryl-based and tricyclic compounds as potential anti-prion agents
@en
P2093
Erika Chung
Stephen Dealler
Woo Sirl Lee
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0024844
P407
P577
2011-01-01T00:00:00Z